Scandinavian ChemoTech AB Series B (CMOTEC-B) — Net Asset Quality Index
Scandinavian ChemoTech AB Series B (CMOTEC-B) has a Net Asset Quality Index of 35.6% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr17.38 Million minus total liabilities of Skr11.18 Million yields net assets of Skr6.19 Million. A higher index indicates a stronger, lower-leverage balance sheet. Also explore CMOTEC-B total assets for the complete picture of this company's asset base.
Quality Index
Net Assets
Total Assets
Total Liabilities
Scandinavian ChemoTech AB Series B Net Asset Quality Index Over Time (2014–2024)
This chart shows how Scandinavian ChemoTech AB Series B's Net Asset Quality Index has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the index stands at 35.6%, representing net assets of Skr6.19 Million against total assets of Skr17.38 Million SEK. See Scandinavian ChemoTech AB Series B working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Scandinavian ChemoTech AB Series B (2014–2024)
The table below presents the year-by-year Net Asset Quality Index for Scandinavian ChemoTech AB Series B from 2014 to 2024, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CMOTEC-B market cap overview.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 44.7% | Skr5.98 Million | Skr13.38 Million | Skr7.40 Million | ▼ -29.5 pp |
| 2023 | 74.2% | Skr11.03 Million | Skr14.87 Million | Skr3.84 Million | ▲ +9.7 pp |
| 2022 | 64.5% | Skr13.99 Million | Skr21.70 Million | Skr7.71 Million | ▼ -28.2 pp |
| 2021 | 92.7% | Skr23.92 Million | Skr25.81 Million | Skr1.89 Million | ▲ +34.9 pp |
| 2020 | 57.8% | Skr9.24 Million | Skr15.99 Million | Skr6.75 Million | ▲ +2.1 pp |
| 2019 | 55.6% | Skr9.73 Million | Skr17.49 Million | Skr7.76 Million | ▼ -34.2 pp |
| 2018 | 89.9% | Skr20.50 Million | Skr22.81 Million | Skr2.31 Million | ▲ +9.8 pp |
| 2017 | 80.1% | Skr10.29 Million | Skr12.84 Million | Skr2.56 Million | ▼ -6.6 pp |
| 2016 | 86.7% | Skr14.58 Million | Skr16.83 Million | Skr2.24 Million | ▲ +73.6 pp |
| 2015 | 13.1% | Skr868.64K | Skr6.65 Million | Skr5.78 Million | ▼ -57.2 pp |
| 2014 | 70.2% | Skr46.27K | Skr65.90K | Skr19.63K | — |